Filing Details
- Accession Number:
- 0001209191-19-013589
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-26 16:51:25
- Reporting Period:
- 2019-02-22
- Accepted Time:
- 2019-02-26 16:51:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197355 | J Henry Fuchs | Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-22 | 20,000 | $33.67 | 26,332 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-22 | 6,479 | $27.75 | 32,811 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-22 | 11,479 | $82.11 | 21,332 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-22 | 14,490 | $81.70 | 6,842 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-22 | 510 | $82.25 | 6,332 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-02-25 | 3,521 | $27.75 | 9,853 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-25 | 3,000 | $78.88 | 6,853 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-25 | 521 | $79.80 | 6,332 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option (right to buy) | Disposition | 2019-02-22 | 20,000 | $0.00 | 20,000 | $33.67 |
| Common Stock | Director Stock Option (right to buy) | Disposition | 2019-02-22 | 6,479 | $0.00 | 6,479 | $27.75 |
| Common Stock | Director Stock Option (right to buy) | Disposition | 2019-02-25 | 3,521 | $0.00 | 3,521 | $27.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-09-17 | No | 4 | M | Direct | |
| 3,521 | 2015-06-06 | 2024-06-06 | No | 4 | M | Direct |
| 0 | 2015-06-06 | 2024-06-06 | No | 4 | M | Direct |
Footnotes
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $82.00 to $82.34.
- Represents weighted average sale price. Actual sale prices ranged from $81.21 to $82.20.
- Represents weighted average sale price. Actual sale prices ranged from $82.21 to $82.2538.
- Represents weighted average sale price. Actual sale prices ranged from $78.50 to $79.17.
- Represents weighted average sale price. Actual sale prices ranged from $79.54 to $80.02.
- The option became exercisable as to 25% of the shares on September 17, 2014, and became exercisable as to 1/48th of the shares each full month thereafter.
Billionaire Hedge Funds
